The Impact of COVID-19 Vaccines on Cancer and Immune Response: Insights from Professor Angus Dalgleish

Introduction

In a recent discussion, Professor Angus Dalgleish shared his observations regarding the effects of COVID-19 vaccines on cancer patients and the immune system. The conversation highlighted concerns about the suppression of T-cell responses in patients who received multiple doses of the COVID vaccine, and how this may have led to a rise in cancer relapses and new cancer cases.

The Senate Hearing

Professor Dalgleish was invited to testify before the US Senate at the request of Senator Ron Johnson, who aimed to shed light on the implications of vaccine policies. During the hearing, Dalgleish emphasized the suppression of scientific findings regarding the immunological effects of the vaccines, particularly in cancer patients. Despite the significant data he presented, mainstream media largely ignored the hearing.

Observations on Cancer Patients

Dalgleish observed a concerning trend among his melanoma patients who had previously achieved complete disease-free status. Within a short period, several patients relapsed after receiving their COVID-19 booster doses. He noted that this type of relapse was unusual based on his decade-long experience, where such occurrences typically happened only every few years and were linked to significant psychological stress rather than vaccination.

T-cell Suppression and Cancer

The professor posited that the third dose of the vaccine might be suppressing T-cell responses crucial for controlling cancer. His theory was supported by research from Madrid, which indicated a phenomenon known as T-cell exhaustion post-vaccination. Despite raising these concerns with hospital authorities, he faced resistance, with officials advocating for more boosters in at-risk patients.

Hyper-Progression of Cancer

Dalgleish and his colleagues have reported an alarming increase in aggressive cancers, termed "hyper-progression", occurring in patients after vaccination. This phenomenon has been particularly noted in various cancer types, including breast, prostate, and colorectal cancers. Clinicians have observed that patients are presenting with advanced-stage cancer far more frequently than in previous years.

Potential Mechanisms

Professor Dalgleish suggested that the spike protein from the mRNA vaccines could interfere with tumor suppressor genes, potentially leading to an increase in oncogenic activity. He also highlighted that the messenger RNA could insert itself randomly into human DNA, raising concerns about long-term implications for cellular health.

Alternative Treatments

Throughout the conversation, Dalgleish mentioned alternative immunomodulatory treatments that could potentially improve patient outcomes without the risks associated with vaccines. He discussed the benefits of low-dose naltrexone and a heat-killed mycobacterium treatment, which have shown promise in enhancing the immune response and controlling cancer growth.

Conclusion

The dialogue with Professor Dalgleish underscores the urgent need to investigate the long-term effects of COVID-19 vaccinations, particularly in vulnerable populations such as cancer patients. His observations and concerns call for further research and transparency in the medical community to ensure patient safety and effective treatment strategies.

Key Takeaways

• Professor Angus Dalgleish observed an increase in cancer relapses among patients post-COVID vaccination.
• The phenomenon of T-cell suppression was highlighted as a potential cause of cancer recurrence.
• “Turbo cancers” or hyper-progression of various cancer types have been noted since the rollout of vaccines.
• Dalgleish advocates for alternative treatments, such as low-dose naltrexone and immunomodulatory therapies, which may offer better outcomes.
• The need for independent research and transparency surrounding vaccine effects is critical.

Health-Related Compounds Mentioned

• Low-Dose Naltrexone
• Heat-Killed Mycobacterium

TLDR Summary

Professor Angus Dalgleish's testimony reveals troubling observations regarding the impact of COVID-19 vaccines on cancer patients, specifically the suppression of T-cell responses leading to increased cancer relapses. He advocates for alternative immunomodulatory treatments and emphasizes the need for further research into vaccine safety and efficacy.

Authors/Speakers

• Professor Angus Dalgleish
• Senator Ron Johnson

Video Relevance

This video content is directly related to health and wellness, focusing on vaccine effects on cancer patients, alternative treatments, and the implications for the medical community.